Form D · Biotechnology
KBI Biopharma Inc.
Durham, NC · CIK 0001314013
Offering snapshot reported Sep 23, 2009 · SEC filing
- Reported sold
- $9.6M Offering amount: $10M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 14, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2009 | Initial | $9,600,000 | No comparison | 9 | SEC filing |
| Dec 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 10, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-72839
Source: Form D, filed Sep 23, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Auman, Jr. | Director |
| Harrington Bischof | Director |
| Richard Brandewie | Director |
| James Hoover | Director |
| Nicholas J Leb | Executive |
| Joseph Mc Mahon | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1101 Hamlin Rd
Durham, NC, 27704
Durham, NC, 27704